TNF and acute myeloid leukemia: Our study revealed that age above 65 years, PLT count (<40 000 cells/mm3), TNF‐α rs1800750 variant genotype, blast percentage (>70%), LDH level (≥600 IU/L), and cytogenetic high risk may be used as independent risk factors for assessing AML mortality.